Trials / Recruiting
RecruitingNCT06848166
Study of the Effectiveness and Safety of Embolization of the Middle Meningeal Artery Using Non-adhesive Materials SQUID 12 and SQUID 18 in the Treatment of Patients With Chronic Resistant Migraine
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Vedanta University Clinic · Academic / Other
- Sex
- All
- Age
- 35 Years – 59 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effectiveness and safety of middle meningeal artery (MMA) embolization using non-adhesive materials SQUID 12 and SQUID 18 as a treatment method for patients with chronic resistant migraine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | liquid embolic agent SQUID 12, liquid embolic agent SQUID 18 | Total endovascular embolization of the frontal and parietal branches (less often the occipital branch) of the middle meningeal artery (MMA) with its complete devascularization. In the case of unilateral pain localization, ipsilateral MMA embolization will be performed; in the case of bilateral pain localization, total embolization of both MMA branches will be performed. |
Timeline
- Start date
- 2024-10-25
- Primary completion
- 2026-10-01
- Completion
- 2027-05-01
- First posted
- 2025-02-26
- Last updated
- 2025-02-26
Locations
1 site across 1 country: Kyrgyzstan
Source: ClinicalTrials.gov record NCT06848166. Inclusion in this directory is not an endorsement.